Administration of oral prednisolone to prevent esophageal stricture after balloon-type radiofrequency ablation for ultralong-segment esophageal neoplasia
CONCLUSIONS: Oral prednisolone may offer a useful and safe preventive option for post-RFA stricture in ultralong ESCNs.CLINICAL TRIAL REGISTRATION NUMBER: NCT05768282.PMID:38583540 | DOI:10.1016/j.gie.2024.03.030
Source: Cancer Control - Category: Cancer & Oncology Authors: Wen-Lun Wang Ying-Nan Tsai Ming-Hung Hsu Jaw-Town Lin Hsiu-Po Wang Ching-Tai Lee Source Type: research
More News: Cancer | Cancer & Oncology | Candida | Clinical Trials | Esophagus Cancer | Gastroenterology | History of Medicine | Lower Endoscopy | Oral Cancer | Pathology | Prednisolone | Squamous Cell Carcinoma | Study